ArticleBMC infectious diseases2026
Human exposure to Crimean-Congo hemorrhagic fever virus is associated with livestock management and handling practices in southcentral Tanzania, 2023-2024.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCrimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne zoonotic pathogen widely distributed across Africa, Asia, and Europe. Human infection occurs through tick bites or contact with infected animal tissues. In Tanzania, evidence of human exposure exists, but data on population-level seroprevalence and associated behavioral risk factors remain limited. This study assessed human CCHFV seroprevalence and identified demographic, behavioral, and environmental factors associated with prior exposure in livestock-keeping communities in southcentral Tanzania.
methodsA community-based cross-sectional study was conducted in four districts of southcentral Tanzania during 2023-2024. A total of 850 adults completed structured questionnaires on demographic and behavioral factors and provided blood samples. Serum samples were tested for CCHFV IgG antibodies using a commercial ELISA. Logistic regression models were used to identify factors associated with seropositivity.
resultsOverall CCHFV seroprevalence was 3.41% (29/850). Seroprevalence increased with age and was highest among participants aged ≥ 51 years (6.28%, p = 0.044). In multivariable analysis, three factors were significantly associated with seropositivity: households with three or more children under five years of age (adjusted OR = 3.45, 95% CI 1.13-10.53, p = 0.030); butchering and consuming animals that died of illness (adjusted OR = 5.48, 95% CI 1.96-15.36, p = 0.001); and grazing animals on private land without other livestock, which was protective (adjusted OR = 0.32, 95% CI 0.12-0.90, p = 0.030).
conclusionsHuman CCHFV exposure in southcentral Tanzania is associated with household composition, animal-handling practices, and grazing behaviors. These findings highlight modifiable behavioral risk factors that may inform targeted public health interventions. As this study focuses on human serologic evidence of prior exposure, further integrated human-animal investigations are needed to better understand transmission dynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.